Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Gainers
NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
COLUMBUS, Ohio, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Intellinetics, Inc., (OTCQB:INLX), a provider of solutions and services that enable and accelerate digital transformation, today announced that its common stock has been